购物车
  • TargetMol
    您的购物车当前为空

Seratrodast

Synonyms: 塞曲司特, ABT-001, AA 2414
货号 T0212Cas号 112665-43-7 一键复制产品信息纯度: 99.69%
Rating icon 很棒

Seratrodast (ABT-001) 是一种血栓素 A2 受体 (TP) 拮抗剂,用于治疗哮喘。

Seratrodast

一键复制产品信息
Rating icon 很棒

纯度: 99.69%

货号 T0212Cas号 112665-43-7

别名 塞曲司特, ABT-001, AA 2414

Seratrodast (ABT-001) 是一种血栓素 A2 受体 (TP) 拮抗剂,用于治疗哮喘。

Seratrodast
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

规格价格库存数量
5 mg
¥ 255
现货
10 mg
¥ 413
现货
25 mg
¥ 637
现货
50 mg
¥ 828
现货
100 mg
¥ 1,370
现货
200 mg
¥ 2,080
现货
500 mg
¥ 3,530
现货
1 mL x 10 mM (in DMSO)
¥ 327
现货
库存状态实时更新,以官网显示为准,现货产品可直接加购物车下单
大包装 & 定制
加入购物车

TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

实验操作小课堂
常见问题解答
查看更多

选择批次:
纯度: 99.69%
颜色: 白色
性状: Solid
资源下载: COA LCMS HNMR产品操作手册

产品介绍


Seratrodast AI Summary
Seratrodast exhibits a broad range of bioactivities across multiple assays and targets. It shows potent inhibition of U-46619-induced contraction of guinea pig lung membranes (Kd = 5.129 nM) and U-44069-induced aggregation of guinea pig platelets (IC50 = 350.0 nM). Demonstrating significant efficacy in various biological systems, it effectively inhibits U-44,069-induced contraction of rabbit aorta and platelet aggregation, and possesses anti-bronchoconstriction properties validated by in vivo studies. Despite this, its inhibition effects on the vitamin D receptor, malarial parasite plastid, USP1/UAF1, and others, display significantly lower potency, most notably with USP1/UAF1 (89,125.1 nM) and vitamin D receptor (44,668.4 nM). Seratrodast shows moderate metabolic stability with high lipophilicity (LogD7.4 = 2.48), an intrinsic clearance of 85.0 uL.min-1.(10^6 cells)-1 in rat hepatocytes, and 3.0 mL.min-1.g-1 in human liver microsomes. It exhibits a high plasma protein binding of 98.0%. It also acts as an inhibitor of human BSEP (IC50 < 14,310.0 nM) and shows mixed results on cell viability across various cell types, such as HEK293T and U2OS cells. While exhibiting some antiviral activities against SARS-CoV-2 and Ebola Virus with low and mixed inhibitory effects, Seratrodast also demonstrates HDAC6 inhibition (36.44% inhibition in enzyme assay). Additionally, it affects the thermal stability of various protein domains and has significant, though variable, impacts on GPCR beta-arrestin recruitment assays across multiple targets. Overall, Seratrodast has significant potential in anti-inflammatory and anti-contraction applications with a diverse range of biological activities, though with relatively lower potency against several enzymes and receptors..
Note: Summary generated by AI. Data source: ChEMBL
生物活性
产品描述
Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.
别名
塞曲司特, ABT-001, AA 2414
化学信息
分子量354.44
分子式C22H26O4
CAS No.112665-43-7
SmilesC(CCCCCC(O)=O)(C1=C(C)C(=O)C(C)=C(C)C1=O)C2=CC=CC=C2
密度1.14 g/cm3
储存&溶解度
存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

实际储存温度请以COA为准

溶解度信息
DMSO: 50 mg/mL (141.07 mM), Sonication is recommended.
体内实验配方
10% DMSO+90% Saline: 2.5 mg/mL (7.05 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM2.8214 mL14.1068 mL28.2135 mL141.0676 mL
5 mM0.5643 mL2.8214 mL5.6427 mL28.2135 mL
10 mM0.2821 mL1.4107 mL2.8214 mL14.1068 mL
20 mM0.1411 mL0.7053 mL1.4107 mL7.0534 mL
50 mM0.0564 mL0.2821 mL0.5643 mL2.8214 mL
100 mM0.0282 mL0.1411 mL0.2821 mL1.4107 mL
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL
母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如: DMSOPEG300PEG400Tween 80SBE-β-CD玉米油等, 均可在TargetMol网站点击购买。
1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

Related Tags: buy Seratrodast | purchase Seratrodast | Seratrodast cost | order Seratrodast | Seratrodast chemical structure | Seratrodast formula | Seratrodast molecular weight